← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2008Last known activity
Jul 17, 2018
Timeline
2000s
- Jan 1, 2005
Hannover Clinical Trial Center GmbH— Founded
Drugs by trial phase (31 distinct, 16 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Iron-Deficiency
- Astrocytoma
- Borderline Personality Disorder
- Carcinoma, Non-Small-Cell Lung
- Cholangiocarcinoma
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Fibrosis
- Glioblastoma
- Glioma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hepatitis D
- Hepatitis D, Chronic
- Hypertension
- Hypertension, Pulmonary
- Infections
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Lung Neoplasms
- Neoplasms, Neuroepithelial
- Personality Disorders
- Retinal Diseases
- Schizophrenia
- Virus Diseases
Recent trials (16)
- NCT03243461CollaboratorPhase 3Jul 17, 2018
- NCT03371173Overall official - principal investigatorPhase 3Mar 27, 2018
- NCT02728778Study chairPhase 2Sep 1, 2016
- NCT03003338CollaboratorPhase 4May 1, 2016
- NCT02728453CollaboratorPhase 4May 1, 2016
- NCT02309918CollaboratorPhase 2Nov 1, 2014
- NCT02040441CollaboratorPhase 2/Phase 3Nov 1, 2013
- NCT01534702CollaboratorPhase 1/Phase 2Jan 1, 2012
- NCT01423175CollaboratorPhase 2Jul 1, 2011
- NCT01320254CollaboratorPhase 2Jun 1, 2011
- NCT01341106CollaboratorPhase 4Apr 1, 2011
- NCT00606723Lead sponsorPhase 3Apr 1, 2010
- NCT01058759CollaboratorPhase 3Nov 1, 2009
- NCT01071135CollaboratorPhase 3Sep 1, 2009
- NCT00932971CollaboratorPhase 2Jun 1, 2009
Details
- Founded
- Hannover, DE Jan 1, 2005
- Last known activity
- Jul 17, 2018